Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Other Non Operating Income (2021 - 2025)

Kiora Pharmaceuticals' Other Non Operating Income history spans 6 years, with the latest figure at -$26755.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 127.64% year-over-year to -$26755.0; the TTM value through Dec 2025 reached -$160272.0, down 714.7%, while the annual FY2025 figure was -$160272.0, 714.7% down from the prior year.
  • Other Non Operating Income reached -$26755.0 in Q4 2025 per KPRX's latest filing, down from -$23708.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $278190.0 in Q2 2021 to a low of -$93556.0 in Q2 2025.
  • Average Other Non Operating Income over 5 years is $12412.1, with a median of -$17557.0 recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: soared 11182.28% in 2023, then crashed 396.03% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $278190.0 in 2021, then plummeted by 99.66% to $937.0 in 2022, then tumbled by 7106.62% to -$65652.0 in 2023, then surged by 247.44% to $96797.0 in 2024, then plummeted by 127.64% to -$26755.0 in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Other Non Operating Income are -$26755.0 (Q4 2025), -$23708.0 (Q3 2025), and -$93556.0 (Q2 2025).